Historical Stock Price
| Home |
| Free Dividend Report |
| Stock Splits Calendar |
| ABIO Historical Stock Prices |
| Preferred Stock Newsletter |
| ABIO Options Chain |
| Stock Message Boards |
ARCA biopharma (ABIO) has the following price history information. Looking back at ABIO historical stock prices for the last five trading days, on August 08, 2022, ABIO opened at $2.40, traded as high as $2.40 and as low as $2.33, and closed at $2.38. Trading volume was a total of 45.80K shares. On August 09, 2022, ABIO opened at $2.38, traded as high as $2.46 and as low as $2.37, and closed at $2.43. Trading volume was a total of 45.10K shares. On August 10, 2022, ABIO opened at $2.43, traded as high as $2.44 and as low as $2.35, and closed at $2.42. Trading volume was a total of 24.90K shares. On August 11, 2022, ABIO opened at $2.44, traded as high as $2.47 and as low as $2.38, and closed at $2.40. Trading volume was a total of 20.40K shares. On August 12, 2022, ABIO opened at $2.40, traded as high as $2.47 and as low as $2.39, and closed at $2.47. Trading volume was a total of 30.20K shares.
ABIO Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into ARCA biopharma shares, starting with a $10,000 purchase of ABIO, and working forward through the historical stock price information to today.
|
Growth of $10,000.00 Without Dividends Reinvested |
||
| Start date: | 08/14/2012 | |
| End date: | 08/12/2022 | |
| Start price/share: | $257.04 | |
| End price/share: | $2.47 | |
| Dividends collected/share: | $0.00 | |
| Total return: | -99.04% | |
| Average Annual Total Return: | -37.16% | |
| Starting investment: | $10,000.00 | |
| Ending investment: | $96.02 | |
| Years: | 10.00 | |
 | |||||
| ABIO Historical Price Range | |||||
| Date | Open | High | Low | Close | Volume |
| 08/08/2022 | $2.40 | $2.40 | $2.33 | $2.38 | 45.80K |
| 08/09/2022 | $2.38 | $2.46 | $2.37 | $2.43 | 45.10K |
| 08/10/2022 | $2.43 | $2.44 | $2.35 | $2.42 | 24.90K |
| 08/11/2022 | $2.44 | $2.47 | $2.38 | $2.40 | 20.40K |
| 08/12/2022 | $2.40 | $2.47 | $2.39 | $2.47 | 30.20K |
|
| About ARCA biopharma |
| ARCA biopharma is a clinical-stage biopharmaceutical company. Co.'s primary product candidates are Recombinant Nematode Anticoagulant Protein c2 (rNAPc2 (AB201)) as a potential treatment for COVID-19, the disease syndrome caused by the SARS-CoV-2 virus, and potentially other viral diseases and Gencaro™ (bucindolol hydrochloride) for the treatment of atrial fibrillation in patients with chronic heart failure. rNAPc2 targets COVID-19 patients with biomarker evidence of coagulopathy, while Gencaro is being developed for patients who have a genotype that identifies a drug target associated with heightened efficacy. |
| ABIO Historical Closing Prices | |
| Date | Close |
| 08/08/2022 | $2.38 |
| 08/09/2022 | $2.43 |
| 08/10/2022 | $2.42 |
| 08/11/2022 | $2.40 |
| 08/12/2022 | $2.47 |
| Healthcare Historical Prices |
| ABIO is categorized under the Healthcare sector; below are some other companies in the same sector:
ABMD Historical Stock Prices Also explore: ABIO shares outstanding history
|
Free ABIO Email Alerts:
